glp 1 and joint pain Glucagon-like peptide-1 receptor agonists in arthritis: current insights future directions GLP-1 Inhibitor Reduces Knee Osteoarthritis

This shift indicates a broader trend among insurers, where approximately 60% of plans include medications for obesity-related conditions, though stringent criteria often apply

#HLTH2025 #EmployerHealth #GLP1 #FutureOfWork #MakingMoments To view or add a comment, sign in The MercerMarsh Benefits 2026 Health Trends report forecasts continued high medical trend rates globally, driven by inflation and increased utilization, while in the US, total health benefit costs per employee are projected to rise by an average of 6.5%

Fast forward to today, and that commitment is stronger than ever

Keep you feeling full longer - smaller portions are enough

We provide the accountability, the clinical expertise, and the compassionate care necessary to turn a weight loss injection into a lifelong health transformation